Home
Conditions
Dyskinesias

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

123 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia

NCT00105508

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Birmingham, Alabama, United States

Huntsville, Alabama, United States

La Jolla, California, United States

Oxnard, California, United States

View all 31 locations

View Trial Details

Completed

Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids

NCT01563913

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: VA Portland Health Care System, Portland, OR Portland, Oregon, United States

View Trial Details

Completed

Sleep Homeostasis in Parkinson's Disease

NCT02200887

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Ospedale Regionale di Lugano Lugano, Canton Ticino, Switzerland

View Trial Details

Completed

Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

NCT00105521

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Phoenix, Arizona, United States

Phoenix, Arizona, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

View all 32 locations

View Trial Details

Completed

Kinesia 360 Parkinson's Monitoring Study

NCT02657655

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

University of Rochester Rochester, New York, United States

Cleveland Clinic Cleveland, Ohio, United States

Greenville Health System Greenville, South Carolina, United States

View Trial Details

Completed

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

NCT02136914

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

Sun City, Arizona, United States

View all 46 locations

View Trial Details

Completed

Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia

NCT01797484

Conditions: Acute Myocardial Ischemia, Arterial Occlusive Diseases, Arteriosclerosis, +15 more
Locations: University Heart Center Hamburg Eppendorf Hamburg, Germany

View Trial Details

Completed

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

NCT02274766

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Fountain Valley, California, United States

Sunnyvale, California, United States

Boca Raton, Florida, United States

Jacksonville, Florida, United States

View all 51 locations

View Trial Details

Completed

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

NCT01397422

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Sun City, Arizona, United States

Fountain Valley, California, United States

Long Beach, California, United States

Los Angeles, California, United States

View all 33 locations

View Trial Details

Completed

ACP-103 to Treat Parkinson's Disease

NCT00086294

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Dyskinesias

Dyskinesias trial results

Related conditions